Powder: -20°C for 3 years | In solvent: -80°C for 1 year
P32/98 hemifumarateis a potent inhibitor of dipeptidyl peptidase IV with a K i value of 130 nM. P32/98 hemifumarate improves glucose tolerance, insulin sensitivity and β-cell responsiveness in fatty Zucker rat model. P32/98 has the potential to prevent type 2 diabetes [1] [2] [3].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 93.00 | |
5 mg | In stock | $ 228.00 | |
10 mg | In stock | $ 342.00 | |
25 mg | In stock | $ 568.00 | |
50 mg | In stock | $ 812.00 | |
100 mg | In stock | $ 1,090.00 | |
500 mg | In stock | $ 2,180.00 |
Description | P32/98 hemifumarateis a potent inhibitor of dipeptidyl peptidase IV with a K i value of 130 nM. P32/98 hemifumarate improves glucose tolerance, insulin sensitivity and β-cell responsiveness in fatty Zucker rat model. P32/98 has the potential to prevent type 2 diabetes [1] [2] [3]. |
In vitro | Following food intake, Glucagon-like peptide 1 (GLP-1) is released into the bloodstream, where it promotes glucose-dependent insulin secretion and induces feelings of satiety. The primary enzymatic pathway for GLP-1 breakdown in the body involves Dipeptidyl Peptidase-IV (DPPIV). Research demonstrates that the presence of P32/98 hemifumarate, in conjunction with 200 pM GLP-1 (10 μM; 3 h), does not significantly affect sodium re-absorption in porcine proximal tubular cells. Furthermore, treatment with P32/98 hemifumarate (10 μM; 96 h) does not alter the mRNA expression of GLP-1R, DPPIV, Na+/H+ exchanger isoform 3 (NHE3), or the sodium-dependent glucose transporters slc5a1 and slc5a2 (SGLT1, 2). A cell cytotoxicity assay conducted on porcine proximal tubular cells at a concentration of 10 μM for 96 hours revealed no toxic effects, affirming the compound's safety at the tested concentration and duration. |
In vivo | Long-term administration of P32/98 hemifumarate (25 mg/kg; i.g.; once daily) significantly enhances glucose tolerance in Zucker diabetic fatty rats, which are a model of IGT (impaired glucose tolerance) [3]. This regimen involved oral gavage of the specified dose daily, demonstrating a noteworthy improvement in glucose tolerance within this animal model [3]. |
Molecular Weight | 520.7 |
Formula | C22H40N4O6S2 |
CAS No. | 251572-86-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
P32/98 (hemifumarate) 251572-86-8 P32/98 inhibitor inhibit